Who Exports Nitrofurantoin from India — 199 Suppliers Behind a $34.2M Market
India's nitrofurantoin export market is supplied by 199 active exporters who collectively shipped $34.2M across 1,809 shipments. MANKIND PHARMA LIMITED leads with a 38.1% market share, followed by CAPLIN POINT LABORATORIES LIMITED and INVENTIA HEALTHCARE LIMITED. The top 5 suppliers together control 72.8% of total export value, reflecting a concentrated market structure.
Top Nitrofurantoin Exporters from India — Ranked by Export Value
MANKIND PHARMA LIMITED is the leading nitrofurantoin exporter from India, holding a 38.1% share of the $34.2M market across 1,809 shipments from 199 exporters. The top 5 suppliers — MANKIND PHARMA LIMITED, CAPLIN POINT LABORATORIES LIMITED, INVENTIA HEALTHCARE LIMITED, EMCURE PHARMACEUTICALS LIMITED, SANDOZ PRIVATE LIMITED — collectively control 72.8% of total export value, indicating a highly concentrated market. Individual shares are: MANKIND PHARMA LIMITED (38.1%), CAPLIN POINT LABORATORIES LIMITED (12.4%), INVENTIA HEALTHCARE LIMITED (11.6%), EMCURE PHARMACEUTICALS LIMITED (6.3%), SANDOZ PRIVATE LIMITED (4.4%).
Top Nitrofurantoin Exporters from India
Ranked by export value · 199 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MANKIND PHARMA LIMITED NITROFURANTOIN CAPSULES USP 100MG [4272 PACKS X 100S] [NITROFURANTOIN CAPSULES USP MACROCRYSTANITROFURANTOIN CAPSULES USP100 MG 100 | $13.0M | 1 | 38.1% |
| 2 | CAPLIN POINT LABORATORIES LIMITED NITROFURANTOIN ORAL SUSPENSION BP 25MG/5NITROFURANTOIN TABLETS USP 100MGNITROFURANTOIN TABLETS USP 100MG NITROFU | $4.2M | 4 | 12.4% |
| 3 | INVENTIA HEALTHCARE LIMITED NITROFURANTOIN CAPSULES USP 100MG [4272 PACKS X 100S] [NITROFURANTOIN CAPSULES USP MACROCRYSTANITROFURANTOIN CAPSULES USP100 MG 100 | $4.0M | 1 | 11.6% |
| 4 | EMCURE PHARMACEUTICALS LIMITED ARX-NITROFURANTOIN 100MG CAPSULE 3X10 (NARX-NITROFURANTOIN 50MG CAPSULE 3X10 (NIPHARMACEUTICAL PRODUCT - NITROFURANTOIN100MG CAPSULES | $2.2M | 5 | 6.3% |
| 5 | SANDOZ PRIVATE LIMITED NITROFURANTOIN CAPSULES USP 100MG [4272 PACKS X 100S] [NITROFURANTOIN CAPSULES USP MACROCRYSTANITROFURANTOIN CAPSULES USP100 MG 100 | $1.5M | 1 | 4.4% |
| 6 | RECIPHARM PHARMASERVICES PRIVATE LIMITED NITROFURANTOIN 100MG PR CAPSULES 1X14S | $1.2M | 1 | 3.4% |
| 7 | MANKIND PHARMA LTD NITROFURANTOIN CAPSULES USP 100MG [4272 PACKS X 100S] [NITROFURANTOIN CAPSULES USP MACROCRYSTANITROFURANTOIN CAPSULES USP100 MG 100 | $1.1M | 1 | 3.1% |
| 8 | ZYDUS LIFESCIENCES LIMITED NITROFURANTOIN CAPSULES USP 100MG [4272 PACKS X 100S] [NITROFURANTOIN CAPSULES USP MACROCRYSTANITROFURANTOIN CAPSULES USP100 MG 100 | $615.2K | 1 | 1.8% |
| 9 | MEDREICH LIMITED NITROFURANTOIN 100MG CAPSULES PACK SIZE:100S QTY:2988NITROFURANTOIN CAPSULES 100 MGNITROFURANTION CAPSULES 50MG 30'S | $533.3K | 4 | 1.6% |
| 10 | AUROBINDO PHARMA LIMITED NITROFURANTOIN CAPSULES USP 100MG [4272 PACKS X 100S] [NITROFURANTOIN CAPSULES USP MACROCRYSTANITROFURANTOIN CAPSULES USP100 MG 100 | $525.4K | 4 | 1.5% |
| 11 | AUROBINDO PHARMA LTD NITROFURANTOIN CAPSULES USP 100MG [4272 PACKS X 100S] [NITROFURANTOIN CAPSULES USP MACROCRYSTANITROFURANTOIN CAPSULES USP100 MG 100 | $520.6K | 4 | 1.5% |
| 12 | TITAN LABORATORIES PRIVATE LIMITED NITROFURANTOIN CAPSULES USP100 MG (UROTOUROTOIN XR (NITROFURANTOIN CAPSULES USP1UROTOIN XR ( NITROFURANTOIN CAPSULES USP | $476.6K | 1 | 1.4% |
| 13 | ALEMBIC PHARMACEUTICALS LIMITED NITROFURANTOIN CAPSULES USP 100MG [4272 PACKS X 100S] [NITROFURANTOIN CAPSULES USP MACROCRYSTANITROFURANTOIN CAPSULES USP100 MG 100 | $445.7K | 1 | 1.3% |
| 14 | MACLEODS PHARMACEUTICALS LTD NITROFURANTOIN CAPSULES USP 100 MG 1X100NITROFURANTOIN CAPSULES 100MGNITROFURANTOIN CAPSULES USP 50 MG 1X100 | $372.0K | 6 | 1.1% |
| 15 | SIDMAK LABORATORIES INDIA PRIVATE LIMITED NITROFURANTOIN CAPSULES USP 100MG [4272 PACKS X 100S] [NITROFURANTOIN CAPSULES USP MACROCRYSTANITROFURANTOIN CAPSULES USP100 MG 100 | $365.0K | 1 | 1.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Nitrofurantoin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| MANKIND PHARMA LIMITED | Approved | Yes | Unknown | Multiple | Three manufacturing facilities hold USFDA certification; majority are WHO GMP ce |
| EMCURE PHARMACEUTICALS LIMITED | Warning Letter, 2016 | Unknown | Unknown | Unknown | Received FDA warning letter in 2016 for data integrity violations. |
| ZYDUS LIFESCIENCES LIMITED | Approved | Unknown | Unknown | Multiple | Received USFDA approval for enzalutamide tablets in October 2024. |
| ALEMBIC PHARMACEUTICALS LIMITED | Approved | Unknown | Unknown | Multiple | Received multiple USFDA approvals between 2024 and 2025. |
TransData Nexus reviewed the regulatory standing of 4 leading Nitrofurantoin exporters from India. 3 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 0 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Nitrofurantoin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as India's "Bulk Drug Capital," is renowned for its extensive production of active pharmaceutical ingredients (APIs). The city hosts numerous API manufacturers, including those producing Nitrofurantoin. Companies like Aurobindo Pharma, headquartered in Hyderabad, are significant contributors to the API sector. The presence of specialized industrial zones, such as Genome Valley, further bolsters Hyderabad's capacity for bulk drug manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a prominent hub for pharmaceutical formulations. This region is home to major companies like Intas Pharmaceuticals, which specializes in the production of finished dosage forms. The well-established infrastructure and skilled workforce in this area make it a key player in the formulation of drugs, including Nitrofurantoin.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceutical products. Mumbai, being the financial capital of India, provides robust logistics and port facilities that facilitate the export of drugs like Nitrofurantoin to international markets. Companies such as Cipla, headquartered in Mumbai, leverage this strategic location to distribute their products globally.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, partly due to favorable tax incentives. This area hosts numerous manufacturing units, including those producing Nitrofurantoin formulations. The region's infrastructure supports large-scale production, contributing substantially to India's pharmaceutical output.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the technical and regulatory compliance of suppliers, especially those in Hyderabad for APIs and Ahmedabad-Vadodara for formulations.
- Leverage Export Infrastructure: Utilize the logistical advantages of the Mumbai-Thane-Raigad region to streamline international distribution.
- Monitor Regulatory Changes: Stay informed about policy shifts, particularly in tax incentives in regions like Baddi-Nalagarh, to optimize cost structures.
By strategically sourcing from these diverse pharmaceutical clusters, companies can enhance supply chain resilience and ensure a steady supply of Nitrofurantoin to meet global demand.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Nitrofurantoin exporters from India
Emcure Pharmaceuticals Limited — Emcure Pharmaceuticals lists on NSE and BSE
Emcure Pharmaceuticals launched its initial public offering and listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) in July 2024. - IMPACT: The public listing is expected to enhance Emcure's financial capabilities, potentially increasing its Nitrofurantoin export capacity.
Impact: The public listing is expected to enhance Emcure's financial capabilities, potentially increasing its Nitrofurantoin export capacity.
Mankind Pharma Limited — Mankind Pharma files Draft Red Herring Prospectus for IPO
Mankind Pharma submitted its Draft Red Herring Prospectus to the Securities and Exchange Board of India (SEBI) in December 2023, indicating plans for an initial public offering. - IMPACT: The anticipated IPO could provide Mankind Pharma with additional capital to expand its Nitrofurantoin production and export activities.
Impact: The anticipated IPO could provide Mankind Pharma with additional capital to expand its Nitrofurantoin production and export activities.
Emcure Pharmaceuticals Limited — Emcure Pharmaceuticals files Draft Red Herring Prospectus for IPO
Emcure Pharmaceuticals filed its Draft Red Herring Prospectus with SEBI in March 2024, signaling its intention to go public. - IMPACT: The forthcoming IPO is expected to bolster Emcure's financial resources, potentially enhancing its Nitrofurantoin export capabilities.
Impact: The forthcoming IPO is expected to bolster Emcure's financial resources, potentially enhancing its Nitrofurantoin export capabilities.
Common Questions — Nitrofurantoin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which nitrofurantoin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MANKIND PHARMA LIMITED leads with 201 recorded shipments worth $13.0M. CAPLIN POINT LABORATORIES LIMITED (19 shipments) and INVENTIA HEALTHCARE LIMITED (12 shipments) are also established high-volume exporters.
Q How many nitrofurantoin manufacturers are there in India?
India has 199 active nitrofurantoin exporters with a combined export market of $34.2M across 1,809 shipments to 92 countries. The top 5 suppliers hold 72.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for nitrofurantoin from India?
Average FOB unit price: $15.53 per unit, ranging from $0.01 to $1718.35. Average shipment value: $18.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 199 verified Indian exporters of Nitrofurantoin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,809 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 92 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,809 Verified Shipments
199 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists